Key Insights

Highlights

Treatment Research

1 treatments under study, led by Ifosfamide

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00003292Phase 2Terminated

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Showing all 1 trials

Research Network

Common Treatments

  • Ifosfamide1

Active Sponsors

  • SWOG Cancer Research Network1
  • Eastern Cooperative Oncology Group1
  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Adult Fibrosarcoma1
  • Adult Leiomyosarcoma1
  • Adult Rhabdomyosarcoma1
  • Adult Malignant Meningioma1
  • Chondrosarcoma1

Activity Timeline